Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 6.58
- Piotroski Score 4.00
- Grade N/A
- Symbol (EUCRU)
- Company Eucrates Biomedical Acquisition Corp.
- Price $10.02
- Changes Percentage (-0.69%)
- Change -$0.07
- Day Low $10.01
- Day High $10.02
- Year High $10.63
Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 12/30/2022
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Buy
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.23
- Trailing P/E Ratio 42.820512820513
- Forward P/E Ratio 42.820512820513
- P/E Growth 42.820512820513
- Net Income $5.54 M
